Panel Detail

Sunday, September 9, 2012
10:40 AM - 11:30 AM

Science and Progress at the FDA


John Lim, CEO, Health Sciences Authority, Singapore
Eric Perakslis, Chief Information Officer and Chief Scientist (Informatics), U.S. Food and Drug Administration


Vicki Seyfert-Margolis, Senior Advisor, Science Innovation and Policy, Office of the Commissioner, U.S. Food and Drug Administration
The U.S. Food and Drug Administration, an agency that regulates as much as 25 percent of every consumer dollar, is at the center of the drug and device delivery process. This panel examines what the agency is doing to ensure it has the necessary scientific expertise and technological framework. Panelists will address efforts that are seeking to modernize the review and approval process, take a close look at international collaboration on regulatory processes, and examine global regulatory challenges.

Panel Video

th FDAscienceprogress

Click image above to play video